No profile data available.
Heartflow, Inc. (HTFL) is a healthcare company in the heart treatment equipment industry, based in San Francisco, United States, with about 843 full-time employees.
It reported revenue of $176.03 million for fiscal year 2025, up 39.9% from fiscal year 2024, and net income of -$116.79 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $64.08 million, up 47.6% from a year before. Its market capitalization was $4.33 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.
Heartflow reported $176.03 million in revenue for fiscal year 2025, up 39.9% from $125.81 million in fiscal year 2024. In Q2 2026 revenue was $64.08 million.
$4.33 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include Edwards Lifesciences Corporation (EW), LivaNova PLC (LIVN), Pulse Biosciences, Inc. (PLSE), iRhythm Technologies, Inc. (IRTC).